Clinical Trial Update: Intravenous Heparin as an Adjunct for the Treatment of Anaphylactic Reactions in an Emergency Department [NA]

View source ↗

Summary

A clinical trial evaluating intravenous heparin as an adjunct treatment for anaphylaxis in the emergency department has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaphylaxis

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: University of Missouri, Kansas City | Conditions: Anaphylaxis | NA | Status: WITHDRAWN